StopDownOpen the app

Funding · Healthcare & Life Sciences

Aignosis raises ₹4 crore seed round

By ·

Aignosis logo
Date
Company
Aignosis
What it does
Child autism screening
Kind
Funding
Amount
₹4 Cr
Stage
Seed
Based in
Jaipur
Founded
2024
Sector
Healthcare & Life Sciences

What they do

Aignosis is a Jaipur healthtech startup that screens children for autism signs using a laptop webcam and computer vision

What happened

Antler, Nikhil Kamath and angels including Varun Dua and IIMA Ventures put in ₹4 crore

Why it matters

It will widen screening across India, aiming for at least one lakh screenings by the end of FY27

The details

  • Aignosis raised ₹4 crore in seed funding.
  • Antler and Nikhil Kamath led the round.
  • Angels and IIMA Ventures also joined.
  • Funds will expand its screening platform across India.

The bigger picture

  • Early signs of autism are often missed, and specialists are scarce.
  • A webcam-based test makes early screening cheaper and available in schools and primary health centres.

About the business

  • Aignosis sells an AI-based autism screening tool that checks young children in about 5 minutes.
  • Buyers are clinics, paediatricians, government health centres and schools that run screening for children.
  • It works through a clinic-in-clinic model, placing its screening set-up inside partner clinics.
  • It has rolled out in 20+ government primary health centres in Rajasthan, and works with a pharma firm whose field staff help run screening camps.
  • It reports 8,000+ screenings so far and aims for 1 lakh (100,000) by the end of FY27.
  • It is based in Jaipur and was founded in 2024.

What happens next

  • Reach one lakh screenings by end of FY27
  • Start operations in about 125 schools with Apollo Shines

Investors

Founders

  • Raksheet Jain, Co-founder
  • Divyansh Mangal, Co-founder

Read it as a card in the app

More on Aignosis

Everything on Aignosis →

Same day

All startup news on 1 October 2026 →